- Report
- May 2026
- 594 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 464 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 381 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 468 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 282 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 580 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 568 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 222 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 159 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 216 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 573 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 371 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 279 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 239 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 297 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 215 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 195 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 422 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- February 2026
- 250 Pages
Global
From €3968EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €3968EUR$4,490USD£3,436GBP

Pharmacogenomics is a field of genomics that studies the relationship between an individual's genetic makeup and their response to drugs. It is used to develop personalized medicine, which is tailored to an individual's genetic profile. This field of genomics has the potential to revolutionize the way drugs are developed and prescribed, as it can help to identify which drugs are most effective for a particular patient. It can also help to reduce the risk of adverse drug reactions, as well as reduce the cost of drug development.
Pharmacogenomics is a rapidly growing field, with many companies investing in research and development. Examples of companies in the market include 23andMe, Genomics England, and Illumina. Show Less Read more